Arrow-right Camera
The Spokesman-Review Newspaper

The Spokesman-Review Newspaper The Spokesman-Review

Spokane, Washington  Est. May 19, 1883
Cloudy 48° Cloudy
News >  Health

News Summary: Pfizer gets OK for leukemia drug

Associated Press

WASHINGTON (AP) — FDA APPROVAL: The Food and Drug Administration on Tuesday approved a new drug from Pfizer for treating a rare form of blood and bone-marrow cancer.

BAD BLOOD CELLS: Pfizer’s Bosulif is a daily pill to treat chronic myeloid leukemia, a disease that causes the bone marrow to produce unhealthy white blood cells. White blood cells are needed to help the body fight off infection.

ORPHAN DRUG: An estimated 5,430 patients will be diagnosed with chronic myelogenous leukemia this year, according to the FDA. The agency cleared Bosulif under its program for drugs intended to treat rare diseases.

The Spokesman-Review Newspaper

Local journalism is essential.

Give directly to The Spokesman-Review's Northwest Passages community forums series -- which helps to offset the costs of several reporter and editor positions at the newspaper -- by using the easy options below. Gifts processed in this system are not tax deductible, but are predominately used to help meet the local financial requirements needed to receive national matching-grant funds.

Active Person

Subscribe to the Coronavirus newsletter

Get the day’s latest Coronavirus news delivered to your inbox by subscribing to our newsletter.